Genomic profiling of the FaDu cell line and derived subclones using amplicon-based targeted sequencing. Genomic profiling of the FaDu cell line and derived subclones using amplicon-based targeted sequencing

Mutational profiling by targeted next-generation sequencing of a SCCHN cell line model and single-cell derived subclones displaying varying sensitivity to cisplatin was used to determine the extent of intratumoral heterogeneity and to dissect the molecular mechanisms involved in primary cisplatin resistance and treatment-induced clonal evolution.